This trial is active, not recruiting.

Condition tobacco use
Sponsor Mayo Clinic
Collaborator Yukon Kuskokwim Health Corporation
Start date January 2015
End date August 2015
Trial size 467 participants
Trial identifier NCT02673346, 14-007166


The aims of this study are 1) To assess the prevalence of tobacco use and cessation treatment preferences among YKHC employees, 2) To assess employee's current levels of perceived stress, engagement in physical activity, and feelings of resiliency to inform future tobacco cessation interventions, and to examine the relationship between these factors and tobacco use, and 3) To assess YKHC employees' perceptions and opinions of the hospital's current workplace tobacco policy and expansion of these regulations to all YKHC properties.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective cross-sectional
YKHC employees

Primary Outcomes

current tobacco use
time frame: 7 days

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - YKHC employee - aged 18 years or older - provides consent Exclusion Criteria:

Additional Information

Official title Assessing Tobacco Use and Treatment Preferences Among Alaska Yukon-Kuskokwim Health Corporation Employees
Description All employees at YKHC will be invited to complete an online survey that took approximately 10-15 minutes to complete. All employees will receive information via email, which includes an overview of the project, information regarding privacy and consent, and a link to the survey. Those who wish to do so were able to print a copy of the information for their reference. Employees who wish to participate did so by clicking on the survey link. Those who do not wish to participate could simply delete the email. Participants will be given two weeks to complete the online survey. Individuals who do not respond within the first week, will be sent an automated email reminder. All employees who participate will received a small incentive (approximately $10 in value).
Trial information was received from ClinicalTrials.gov and was last updated in February 2016.
Information provided to ClinicalTrials.gov by Mayo Clinic.